Premier Energies gets Nuvama Buy, TP raised to ₹1,190

What changed for Premier Energies

Nuvama Institutional Equities has maintained a ‘Buy’ call on Premier Energies after what it described as resilient Q4 FY26 results and a bright outlook. The domestic brokerage also raised its target price on the stock. Premier Energies shares edged up 0.14% to close at ₹979 on Friday, reflecting a muted but positive reaction.

The brokerage’s note focuses on operating momentum, visibility from a large order book, and the next phase of manufacturing expansion. It also points to policy levers such as ALMM-II and Domestic Content Requirement (DCR) that could shape demand across rooftop, commercial and industrial (C&I), and eventually utility-scale segments.

Q4 FY26: revenue, EBITDA and margin snapshot

Nuvama reported Q4 FY26 revenue and EBITDA at ₹2,200 crore and ₹670 crore, respectively. That implies year-on-year growth of 38% in revenue and 28% in EBITDA. It attributed the performance to a 17% YoY improvement in module realisation and a 59% YoY rise in cell output.

The brokerage also pegged EBITDA margin at 30% for the quarter. While the note does not provide PAT for Q4 FY26, it frames profitability as resilient despite an ongoing high capex cycle.

Capacity ramp-up: modules and cells timelines

A key part of the thesis is the near-term commissioning and ramp-up of capacity. Nuvama said Premier Energies’ 5.6 GW module capacity is expected to start ramping up from Jul-26. On cells, it noted that 4.8 GW and 2.2 GW capacities are expected to come onstream during Jun-Sep-26.

The ramp schedule matters because Premier Energies manufactures and sells integrated solar cells and modules in India. With domestic demand increasingly shaped by localisation norms, execution of planned capacity and stabilisation of yields can influence both revenue scale and margins.

Order book: 9.4 GW valued at nearly ₹14,000 crore

Nuvama highlighted an order book of 9.4 GW, valued at nearly ₹14,000 crore. This level of backlog offers medium-term revenue visibility, especially as new manufacturing lines are added.

In a separate data point in the provided material, Premier Energies also secured new orders worth ₹2,307.30 crore for execution in FY27-FY28. Together, these updates underline continued booking momentum alongside expansion.

Policy signals: ALMM-II and the DCR mix

The brokerage said implementation of ALMM-II is likely to support demand from rooftop and C&I segments under the DCR framework. It added that utility-scale demand is expected to emerge from FY29 onwards. Nuvama also expects the DCR mix to improve sequentially on a quarter-on-quarter basis.

These comments link demand to policy design, particularly where eligibility and procurement rules favour domestically manufactured modules and cells. For manufacturers, the timing of ALMM-II and the pace of utility-scale ordering can affect volume visibility and pricing.

Capex, leverage and management guardrails

On the expansion front, Nuvama noted Premier Energies has guided FY27 capex at ₹5,100 crore. It also cited estimated capex of ₹12,000 crore over FY26–FY28.

The brokerage flagged that net debt increased 2.7 times quarter-on-quarter amid the high capex cycle. However, it said the company aims to keep debt-to-equity below 1x and debt-to-EBITDA below 1.5x. Nuvama’s note also stated that strong operating cash flow and internal accruals are expected to fund capex, while calling the balance sheet healthy.

New adjacencies: BESS policy and inverter plans

Nuvama said the company expects a battery energy storage system (BESS) policy in the next 3 to 4 months. It also said inverter plans remain active and that a partner tie-up is in progress.

These updates matter because storage and power electronics can expand the addressable market beyond modules and cells. At the same time, the note does not quantify the expected revenue contribution from these plans.

Valuation and target prices: Nuvama vs other broker views

Nuvama said the stock trades at 21x FY28E EPS and reiterated ‘BUY’. It raised its target price to ₹1,190 from ₹1,082.

Other broker notes in the provided material show a range of targets and stances. Motilal Oswal Financial Services initiated coverage with a Buy rating and a target price of ₹1,000, citing the company’s integrated model and capacity ramp-up. Another analyst update referenced a lifted price target to ₹1,003. Separately, ICICI Securities reiterated a ‘BUY’ with a target price of ₹1,320, while Kotak Institutional Equities issued a ‘sell’ rating with a target price of ₹900.

Key data table

Market impact: what investors are tracking now

The immediate market move was modest, with the stock closing slightly higher after the note. For investors, the key variables flagged in the material are the pace of commissioning from Jun-Sep 2026 for cells and the module ramp from Jul-26, order execution against a 9.4 GW backlog, and the impact of ALMM-II on rooftop and C&I demand.

Leverage is also in focus. The note explicitly acknowledges a sharp quarter-on-quarter rise in net debt during the capex cycle, while outlining management’s stated targets for debt-to-equity and debt-to-EBITDA. Any deviation from those guardrails could influence how the market prices growth versus balance sheet risk.

Analysis: why this update matters for the solar manufacturing theme

Nuvama’s commentary highlights a familiar pattern in domestic solar manufacturing: policy-led demand, large capacity announcements, and the need for clean ramp execution to protect margins. The combination of improved module realisations and higher cell output in Q4 FY26 suggests operating leverage, but sustaining profitability through the next investment phase will likely depend on utilisation and mix.

The note also links demand evolution to timing, with rooftop and C&I seen as nearer-term support and utility-scale demand expected from FY29 onwards. That framing matters because it implies a transition in customer mix, contracting cycles, and potentially pricing dynamics as procurement shifts.

Conclusion

Premier Energies remains in focus after Nuvama reiterated ‘Buy’ and raised its target price to ₹1,190 following Q4 FY26 results showing ₹2,200 crore revenue and ₹670 crore EBITDA with a 30% margin. The next milestones, as highlighted in the note, are the Jun-Sep 2026 cell commissioning window, the Jul-26 module ramp-up, and policy developments including ALMM-II implementation and an expected BESS policy in the next 3 to 4 months.